Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3LWJ7
|
|||
| Drug Name |
Natalizumab
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Crohn disease [ICD-11: DD70; ICD-10: K50, K50.9; ICD-9: 555] | Approved | [1] | |
| Multiple sclerosis [ICD-11: 8A40] | Approved | [1] | ||
| Company |
Novartis
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. | |||
| REF 2 | Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring. Front Immunol. 2020 Sep 24;11:549842. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.